Zsuzsanna K.
- Country
- Hungary
- Department
- Oncoradiology Center
Research Overview
- Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Patients With Previously Treated TROP2-Positive Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Phase 1b/2 Umbrella Study of MK-1084 and Combination Therapy in Patients With Previously Treated Advanced or Metastatic KRAS G12C-Mutated Nonsquamous NSCLC
- Phase III Trial of BI 764532 Plus Atezolizumab, Carboplatin, and Etoposide as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 234 of 458 partner sites.
Specializations
Thoracic Oncology
Zsuzsanna Kelemen is involved in clinical research across a broad range of non-small cell lung cancer and small cell lung cancer settings, with interest in locally advanced, metastatic, resectable, and early-stage disease. The portfolio also includes biomarker-defined lung cancer populations and treatment strategies combining immunotherapy, targeted therapy, and chemoradiation.
- Non-small cell lung cancer
- Small cell lung cancer
- PD-L1-selected lung cancer
- Resectable and unresectable thoracic malignancies
The investigator’s thoracic oncology activity reflects engagement with treatment innovation in advanced and early lung cancer, including antibody-drug conjugates and immune checkpoint inhibitors.
Breast and Gynecologic Oncology
Her research landscape includes extensive work in breast cancer, particularly HER2-positive, HER2-low, hormone receptor-positive, triple-negative breast cancer, and early breast cancer. Gynecologic oncology interests extend to ovarian cancer, endometrial cancer, and cervical cancer, with attention to advanced and recurrent disease.
- HER2-positive and HER2-low breast cancer
- Hormone receptor-positive breast cancer
- Triple-negative breast cancer
- Ovarian, endometrial, and cervical cancer
These activities show a strong therapeutic focus on modern breast and gynecologic cancer regimens, including endocrine therapy, HER2-directed treatment, and precision oncology.
Urologic and Genitourinary Malignancies
She is active in studies of urothelial carcinoma, muscle-invasive bladder cancer, and metastatic castration-resistant prostate cancer, as well as other advanced genitourinary tumors. The scope also includes patients with metastatic or unresectable disease requiring systemic treatment options.
- Urothelial carcinoma
- Muscle-invasive bladder cancer
- Metastatic castration-resistant prostate cancer
- Advanced genitourinary cancer
This area highlights involvement in genitourinary oncology with emphasis on immunotherapy and targeted anticancer strategies.
Cardiovascular Medicine and Thrombosis
Zsuzsanna Kelemen’s trial activity also spans acute coronary syndrome, myocardial infarction, heart failure, atrial fibrillation, atherosclerotic cardiovascular disease, and venous thromboembolism. Her research includes patients with high cardiovascular risk and comorbid kidney disease, reflecting a strong interest in cardiometabolic disease management.
- Acute myocardial infarction and acute coronary syndrome
- Heart failure
- Atrial fibrillation
- Venous thromboembolism
The cardiovascular portfolio includes work in antithrombotic therapy, heart failure treatment, and prevention of recurrent cardiovascular events.
Immune-Mediated, Neurologic, and Metabolic Conditions
Her broader clinical research involvement includes rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, hidradenitis suppurativa, and plaque psoriasis, alongside neurologic and psychiatric conditions such as schizophrenia, major depressive disorder, dementia-related agitation, and tardive dyskinesia. The portfolio also covers chronic kidney disease, hypertension, and lipid-related cardiovascular prevention.
- Autoimmune and inflammatory disease
- Psychiatric and neurocognitive disorders
- Chronic kidney disease and hypertension
- Lipid and cardiovascular risk reduction
This range indicates engagement with immunology, neuropsychiatry, and cardiometabolic prevention across chronic disease settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.